TMEM97 and neoplasm: The goal of the current study was to assess the capacity of FDG and the sigma-2 receptor ligand, [18F]ISO-1, to measure two different clinically-relevant properties of solid tumors, proliferative status (P:Q ratio) and tumor growth rate.